Arcellx Aktie - ACLX

Rendering Error

Ihr Hub für Echtzeit-Streaming-Zitate, Ideen und Live-Diskussionen

Premium

Current Price

65,60

Gebot

64,33

Fragen

66,87

Volumen

840.908

61,17 Tagesbereich 65,77

47,88 52-Wochen-Bereich 107,3699

Marktkapitalisierung

3,604B

Handelsende

67,96

Handelsbeginn

65,63

Letzte Trade

171

65.6

(formt)

Letzter Handelszeitpunkt

22:36:18

Finanzvolumen

US$ 53.470.214

VWAP

63,5863

Durchschnittliches Volumen (3 Mio.)

644.990

Ausgegebene Aktien

54.944.012

Dividendenrendite

Kurs-Gewinn-Verhältnis

-33,58

Gewinn pro Aktie (EPS)

-1,95

Erlöse

107,94M

Nettogewinn

-107,35M

Arcellx Inc is a clinical-stage biotechnology company reimagining cell therapy through the development of innovative immunotherapies for patients with cancer and other incurable diseases. Arcellx Inc is a clinical-stage biotechnology company reimagining cell therapy through the development of innovative immunotherapies for patients with cancer and other incurable diseases.

Sektor

Biological Pds,ex Diagnstics

Branche

Biological Pds,ex Diagnstics

Website

www.arcellx.com

Hauptsitz

Wilmington, Delaware, USA

Gegründet

Arcellx Inc is listed in the Biological Pds,ex Diagnstics sector of the NASDAQ with ticker ACLX. The last closing price for Arcellx was US$67,96. Over the last year, Arcellx shares have traded in a share price range of US$ 47,88 to US$ 107,3699.

Arcellx currently has 54.944.012 shares in issue. The market capitalisation of Arcellx is US$3,73 billion. Arcellx has a price to earnings ratio (PE ratio) of -33.58.

Zeitraum †	Änderung	Änderung %	Handelsbeginn	Hoch	Niedrig	Durchsch. Volumen	VWAP
1	-4.39	-6.2723246178	69.99	72.68	65.6	480651	70.52880804	CS
4	0.88	1.35970333745	64.72	73.69	60.82	618229	69.7839689	CS
12	-14.14	-17.7326310509	79.74	79.75	58.2	644990	67.50075522	CS
26	-17.23	-20.8016419172	82.83	107.3699	58.2	598560	77.10749548	CS
52	-3.59	-5.18861107096	69.19	107.3699	47.88	530022	69.70521639	CS
156	52.96	418.987341772	12.64	107.3699	6.035	512450	47.2901532	CS
260	46.6	245.263157895	19	107.3699	6.035	496832	46.72954946	CS

ACLX - Frequently Asked Questions (FAQ)

What is the current Arcellx share price?

The current share price of Arcellx is US$ 65,60

How many Arcellx shares are in issue?

Arcellx has 54.944.012 shares in issue

What is the market cap of Arcellx?

The market capitalisation of Arcellx is USD 3,73B

What is the 1 year trading range for Arcellx share price?

Arcellx has traded in the range of US$ 47,88 to US$ 107,3699 during the past year

What is the PE ratio of Arcellx?

The price to earnings ratio of Arcellx is -33,58

What is the cash to sales ratio of Arcellx?

The cash to sales ratio of Arcellx is 33,39

What is the reporting currency for Arcellx?

Arcellx reports financial results in USD

What is the latest annual turnover for Arcellx?

The latest annual turnover of Arcellx is USD 107,94M

What is the latest annual profit for Arcellx?

The latest annual profit of Arcellx is USD -107,35M

What is the registered address of Arcellx?

The registered address for Arcellx is 1209 ORANGE STREET, WILMINGTON, DELAWARE, 19801

What is the Arcellx website address?

The website address for Arcellx is www.arcellx.com

Which industry sector does Arcellx operate in?

Arcellx operates in the BIOLOGICAL PDS,EX DIAGNSTICS sector

Volumen
% Tops
% Flops

Symbol	Preis	Vol.
BIAFbioAffinity Technologies Inc	US$ 0,475 (82,69%)	10,27M
SBETSharpLink Gaming Inc	US$ 0,4247 (45,95%)	2,48M
NUTXNutex Health Inc	US$ 58,925 (25,29%)	4,42k
PSTVPlus Therapeutics Inc	US$ 1,15 (21,04%)	1,14M
CMPXCompass Therapeutics Inc	US$ 2,2996 (21,03%)	83,93k
AQBAquaBounty Technologies Inc	US$ 0,62 (-10,00%)	10,87k
ONEGOneConstruction Group Limited	US$ 2,05 (-9,69%)	217
CTORCitius Oncology Inc	US$ 0,8401 (-9,67%)	320,74k
TCTMTCTM Kids IT Education Inc	US$ 0,3651 (-8,75%)	25,59k
TRNRInteractive Strength Inc	US$ 1,14 (-7,32%)	146,61k
DMNDamon Inc	US$ 0,0136 (-1,45%)	17,92M
BIAFbioAffinity Technologies Inc	US$ 0,475 (82,69%)	10,27M
ICCTiCoreConnect Inc	US$ 2,4598 (9,81%)	10,14M
NVDANVIDIA Corporation	US$ 108,00 (-0,35%)	4,56M
CSXCSX Corporation	US$ 29,43 (0,00%)	4,38M

Rendering Error

Foren

Foren anzeigen

Keine Diskussionen Gefunden.

Neuen Thread Erstellen

Trends

Toplisten

Marktdaten

News

Werkzeuge

Märkte

Entdecken

Hot Features

Follow Feed

Optionen-Flow

Watchlist

Arcellx Inc (ACLX) Börsenkurse

Arcellx Inc (ACLX)

Ihr Hub für Echtzeit-Streaming-Zitate, Ideen und Live-Diskussionen

Wichtige Statistiken und Details

Über Arcellx Inc

ACLX Neueste Nachrichten

Form 4 - Statement of changes in beneficial ownership of securities

Form 3 - Initial statement of beneficial ownership of securities

Form 8-K - Current report

Arcellx Appoints Andrew Galligan and Kristin Myers to Its Board of Directors

Form 8-K - Current report

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]

Arcellx Provides Fourth Quarter and Year-End 2024 Financial Results and Business Highlights

Arcellx to Participate at the TD Cowen 45th Annual Health Care Conference

Form 4 - Statement of changes in beneficial ownership of securities

Form 144 - Report of proposed sale of securities

Form 4 - Statement of changes in beneficial ownership of securities

Form 3 - Initial statement of beneficial ownership of securities

Form 8-K - Current report

Arcellx Appoints Andrew Galligan and Kristin Myers to Its Board of Directors

Form 8-K - Current report

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]

Arcellx Provides Fourth Quarter and Year-End 2024 Financial Results and Business Highlights

Arcellx to Participate at the TD Cowen 45th Annual Health Care Conference

ACLX - Frequently Asked Questions (FAQ)

Beweger

ACLX Finanzen

Foren

Kürzlich von Ihnen besucht

Unternehmen

Geschäft

Popular

App herunterladen

Werbung entfernen